» Articles » PMID: 20424232

Associations Between Features of Glucose Exposure and A1C: the A1C-Derived Average Glucose (ADAG) Study

Overview
Journal Diabetes
Specialty Endocrinology
Date 2010 Apr 29
PMID 20424232
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Various methods are used to quantify postprandial glycemia or glucose variability, but few have been compared and none are standardized. Our objective was to examine the relationship among common indexes of postprandial glycemia, overall hyperglycemia, glucose variability, and A1C using detailed glucose measures obtained during everyday life and to study which blood glucose values of the day provide the strongest prediction of A1C.

Research Design And Methods: In the A1C-Derived Average Glucose (ADAG) study, glucose levels were monitored in 507 participants (268 type 1 diabetic, 159 type 2 diabetic, and 80 nondiabetic subjects) with continuous glucose monitoring (CGM) and frequent self-monitoring of blood glucose (SMBG) during 16 weeks. We calculated several indexes of glycemia and analyzed their intercorrelations. The association between glucose measurements at different times of the day (pre- and postprandial) and A1C was examined using multiple linear regression.

Results: Indexes of glucose variability showed strong intercorrelation. Among postprandial indexes, the area under the glucose curve calculated from CGM 2 h after a meal correlated well with the 90-min SMBG postprandial measurements. Fasting blood glucose (FBG) levels were only moderately correlated with indexes of hyperglycemia and average or postprandial glucose levels. Indexes derived with SMBG strongly correlated with those from CGM. Some SMBG time points had a stronger association with A1C than others. Overall, preprandial glucose values had a stronger association with A1C than postprandial values for both diabetes types, particularly for type 2 diabetes.

Conclusions: Indexes of glucose variability and average and postprandial glycemia intercorrelate strongly within each category. Variability indexes are weakly correlated with the other categories, indicating that these measures convey different information. FBG is not a clear indicator of general glycemia. Preprandial glucose values have a larger impact on A1C levels than postprandial values.

Citing Articles

Efficacy and safety of iGlarLixi versus insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials.

Li J, Wang X, Wu J, Geng D, Li F, Liu Y Endocrine. 2025; .

PMID: 40011373 DOI: 10.1007/s12020-025-04207-w.


Glycated Haemoglobin (HbA) in Cardiac Surgery: A Narrative Review.

Luthra S, Viola L, Navaratnarajah M, Thirukumaran D, Velissaris T J Clin Med. 2025; 14(1.

PMID: 39797106 PMC: 11721050. DOI: 10.3390/jcm14010023.


Comparative Effectiveness of Oral Hypoglycemic Agents for Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Using Flash Glucose Monitoring.

Venkatachalapathy P, Mohandoss K, Munisamy M, Sellappan M Curr Diabetes Rev. 2024; 21(1):e160124225706.

PMID: 38310479 PMC: 11497140. DOI: 10.2174/0115733998267817231227102553.


Vegetable and Fruit Intake Variety and Cardiovascular Health and Mortality: A Systematic Review and Meta-Analysis of Observational Studies.

Nishi S, Khoury N, Valle Hita C, Zurbau A, Salas-Salvado J, Babio N Nutrients. 2023; 15(23).

PMID: 38068771 PMC: 10707746. DOI: 10.3390/nu15234913.


Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China.

Song L, Cao F, Niu S, Xu M, Liang R, Ding K Clin Pharmacokinet. 2023; 63(1):93-108.

PMID: 37985591 DOI: 10.1007/s40262-023-01321-8.


References
1.
Chiasson J, Josse R, Gomis R, Hanefeld M, Karasik A, Laakso M . Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003; 290(4):486-94. DOI: 10.1001/jama.290.4.486. View

2.
Heine R, Dekker J . Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia. 2002; 45(4):461-75. DOI: 10.1007/s00125-001-0726-0. View

3.
Avignon A, Radauceanu A, Monnier L . Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care. 1997; 20(12):1822-6. DOI: 10.2337/diacare.20.12.1822. View

4.
Service F, MOLNAR G, ROSEVEAR J, ACKERMAN E, Gatewood L, Taylor W . Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970; 19(9):644-55. DOI: 10.2337/diab.19.9.644. View

5.
Ceriello A, Colagiuri S, Gerich J, Tuomilehto J . Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis. 2008; 18(4):S17-33. DOI: 10.1016/j.numecd.2008.01.012. View